This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Iannitti, DavidA. Articles by Dupuy, D. E. Search for Related Content PubMed Articles by Iannitti, DavidA. Articles by Dupuy, D. E. Social Bookmarking                         What's this?

Minimally Invasive Management of Hepatic Metastases

Brown Uniaersity School of Medicine, Providence, RI

Damian E. Dupuy, MD

Brown Uniaersity School of Medicine, Providence, RI

The introduction of laparoscopy for diagnosis of abdominal tumors has also allowed for the destruction of hepatic metastases by cryotherapy and radiofrequency ablation. The advantage of laparoscopically based therapy over the percutaneous treatment is the benefit of finding additional lesions that preoperative studies may not have detected. The results from available data in patients with metastatic colorectal carcinoma suggest an improvement in survival. Tumor ablation in patients offers an 18- to 36-month median survival and the possibility of 50% and 24% survival rates at 2 and 5 years, respectively. Patients with metastases from melanoma, breast, esophagus, lung, stomach, pancreas, and gynecologic malignancies have historically not demonstrated improved survival after hepatic resection. The value of hepatic tumor ablation for metastases from these lesions remains undetermined. Copyright © 2000 by W B. Saunders Company

Key Words: Cryoablation • radiofrequency ablation • liver tumors • laparoscopic.

Surgical Innovation, Vol. 7, No. 2, 118-128 (2000)
DOI: 10.1177/155335060000700207


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?